Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
JNJ | JOHNSON & JOHNSON | United States | $360.79B | 2,406,679,183 | 69.58% | 0.19% | Net Selling | Net Selling |
SNY | SANOFI | France | $124.66B | 1,264,799,969 | 19.51% | 0.00% | ||
LLY | ELI LILLY & CO | United States | $722.31B | 950,405,386 | 82.42% | 11.18% | Net Selling | Net Selling |
BIIB | BIOGEN INC | United States | $32.25B | 145,596,895 | 87.72% | 2.11% | Net Selling | Net Selling |
NVS | NOVARTIS AG | Switzerland | $208.32B | 2,040,400,000 | 6.93% | 0.00% | ||
GSK | GSK PLC | United Kingdom | $91.13B | 4,044,000,000 | 7.28% | 0.00% | ||
AZN | ASTRAZENECA PLC | United Kingdom | $239.28B | 1,550,162,626 | 31.49% | 0.00% | ||
ABBV | ABBVIE INC | United States | $283.86B | 1,765,867,781 | 70.18% | 0.15% | Net Selling | Net Selling |
MRK | MERCK & CO INC | United States | $329.42B | 2,532,806,307 | 76.16% | 0.19% | Net Buying | Net Buying |
GILD | GILEAD SCIENCES INC | United States | $82.18B | 1,245,853,209 | 83.54% | 1.09% | Net Selling | Net Selling |
AMGN | AMGEN INC | United States | $166.38B | 536,434,692 | 76.42% | 1.01% | Net Selling | Net Selling |
BMY | BRISTOL MYERS SQUIBB CO | United States | $91.10B | 2,027,100,096 | 76.28% | 0.36% | Net Selling | Net Selling |
OGN | ORGANON & CO | United States | $5.25B | 257,170,727 | 76.93% | 0.20% | Net Selling | Net Selling |
GRFS | GRIFOLS SA | United States | $4.81B | 687,554,908 | 17.73% | 0.00% | ||
PFE | PFIZER INC | United States | $158.72B | 5,666,592,898 | 68.21% | 0.27% | Net Selling | Net Selling |
SCLX | SCILEX HOLDING CO | United States | $123.81M | 166,189,835 | 15.74% | 37.69% | ||
AMRN | AMARIN CORP PLC | Ireland | $350.47M | 410,868,659 | 22.85% | 15.40% | Net Selling |